ABSTRACT
CONTENTS 12.1 Drug Discovery ................................................................................................................225 12.2 Neurodegeneration and Neuroprotective Agents ....................................................227 12.3 Optimizing Chemical Structures ..................................................................................227 12.4 Target Validation ............................................................................................................228 12.5 Importance of Biomarkers for Target Validation ........................................................229 12.6 Identifying New Molecular Targets ............................................................................230 12.7 Connecting Molecular Targets to Diseases ..................................................................231 12.8 Drug Discovery Strategies for Alzheimer’s Disease ..................................................232
